MENU

Fox Chase Cancer Center News

November 22, 2021

AlphaFold System for Protein Structure Prediction Could Enhance Development of New Drugs

PHILADELPHIA (November 22, 2021)—Fox Chase Cancer Center has begun using a new artificial intelligence-powered system called AlphaFold, which allows researchers to develop accurate predictions of how proteins fold into their final structures, making it a tool that could enhance the development of new drugs.

November 15, 2021

Gary Barbera’s on the Boulevard to Present Check for Breast Cancer Research to Fox Chase Cancer Center

PHILADELPHIA (November 15, 2021)— Gary Barbera and his Barbera Cares Ambassadors of Gary Barbera’s on the Boulevard, in partnership with State Representative Jared G. Solomon, will present a check for $10,000 to Fox Chase Cancer Center on November 22, money that will help improve the lives of patients and families affected by breast cancer.

November 9, 2021

Cihangir Duy Receives Grant to Investigate the Effect of LSD1 Inhibitors on ‘Dormant’ Leukemia Cells

PHILADELPHIA (November 9, 2021)—Cihangir Duy, PhD, MS, an assistant professor in the Cancer Signaling and Epigenetics Program at Fox Chase Cancer Center, has been awarded a one-year $100,000 Hollis Brownstein Research Grant from The Leukemia Research Foundation. The grant will fund research into how certain acute myeloid leukemia (AML) cells can reactivate following chemotherapy, thus causing disease relapse.

November 8, 2021

Fox Chase Cancer Center Receives Two Press Ganey Patient Experience Awards

PHILADELPHIA (November 8, 2021)—Fox Chase Cancer Center has been recognized for excellence in patient care with two Press Ganey Awards, the Pinnacle of Excellence Award and the Guardian of Excellence Award.

November 8, 2021

In Vino Vita, Fox Chase’s Signature Fundraising Event, Raises Over $1.5 Million for Cancer Research, Treatment and Prevention

PHILADELPHIA (November 8, 2021)—In Vino Vita, Fox Chase Cancer Center’s signature fundraising event, was held on October 30 at the National Constitution Center, and raised over $1.5 million for cancer research, treatment and prevention.

November 4, 2021

Artificial Intelligence Could Have an Impact on Kidney Cancer Management

PHILADELPHIA (November 4, 2021)—As more radiographic, histopathologic, and genomic data are gathered and made accessible, it is only a matter of time until artificial intelligence (AI) becomes part of the regular clinical workflow for treating kidney cancer, according to a review article published by researchers at Fox Chase Cancer Center.

November 3, 2021

Benjamin A. Young Appointed Program Manager at the Marvin & Concetta Greenberg Pancreatic Cancer Institute

PHILADELPHIA (November 3, 2021)—Benjamin A. Young, CCRP, has been appointed Program Manager at the Marvin & Concetta Greenberg Pancreatic Cancer Institute, where he will work with researchers to coordinate the institute’s basic, clinical, and population sciences research programs.

November 2, 2021

Marcin Chwistek to Speak at Hospice Care Professionals Association Conference in Russia

PHILADELPHIA (November 2, 2021)—Marcin Chwistek, MD, FAAHPM, director of the Supportive Oncology and Palliative Care Program at Fox Chase Cancer Center, will be speaking virtually at the Hospice Care Professionals Association Conference being held in Moscow November 2-3.

Pages

Connect with Fox Chase